September 13, 2017 Clinical Research/Diagn. M&A, Partnerships

Fabric Genomics and Genome Medical Partner to Help Patients and Clinicians Better Understand Genetic Results

September 13, 2017 06:00 AM Pacific Daylight Time OAKLAND, Calif. & SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Fabric Genomics and Genome Medical announced today that they have entered into a partnership with the goal of bringing expert medical interpretation and counseling around genomic data directly to physicians and patients. Genome Medical will use Fabric Genomics’ clinical interpretation platform, Fabric Enterprise™, for ongoing... Read more

September 11, 2017 Clinical Research/Diagn. PR/Corporate

Wageningen University and Research iGEM 2017

Wageningen University (Netherlands) and Research 2017 iGEM Team participate in the iGEM competition, which is a global competition to tackle real-world problems using synthetic biology. The iGEM competition builds up to the Giant Jamboree at MIT in Boston, where all teams come together to present their project. This year Hamilton Bonaduz AG  sponsor our project!... Read more

September 8, 2017 Clinical Research/Diagn. Mass Spectrometry Product Launch

SCIEX launches the Topaz™ LC-MS/MS System for Clinical Diagnostics in Europe

A fully-integrated CE-marked and FDA Class I medical device demonstrating both open design and capability for locked methods, will be showcased at MSACL EU 2017 September 08, 2017 WARRINGTON UK — SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in life science industry, will be showcasing the SCIEX Topaz™ System for Clinical Diagnostics at the... Read more

September 8, 2017 Clinical Research/Diagn. Lab Top-10 Mass Spectrometry Product Launch

PerkinElmer Launches QSight®210 MD System for Clinical Laboratories

High Throughput Mass Spectrometry-Based Clinical Solution Can Run Hundreds of Samples Per Day  APHL Newborn Screening and Genetic Testing Symposium, New Orleans, Booth #409– September 8, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its QSight® 210 MD system, designed to provide routine high... Read more

September 8, 2017 Clinical Research/Diagn.

Roche announces progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress

Basel, 08 September 2017 Roche announces progress in biomarker science in cancer immunotherapy at the European Society for Medical Oncology Congress First data on new blood-based assay for measuring tumour mutational burden Two prospective studies underway to assess the potential of tumour mutational burden to predict response to certain cancer immunotherapies Roche (SIX: RO, ROG;... Read more

September 7, 2017 Clinical Research/Diagn. Lab Top-10 Life Science Tools

PerkinElmer Extends Clinical Whole Genome Sequencing Services

Provides Families a Novel, Personalized Approach to Managing their Health WALTHAM, Massachusetts – September 7, 2017 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, expanded its Whole Genome Sequencing (WGS) services to families that preserve their cord blood and cord tissue with ViaCord. This launch follows the Company’s recent introduction... Read more

September 7, 2017 Clinical Research/Diagn. Lab Top-10

Institute of Pathology Heidelberg Joins Thermo Fisher Scientific Center of Excellence Program to Drive Oncology Companion Diagnostic Development in Europe

Institute of Pathology Heidelberg Joins Thermo Fisher Scientific Center of Excellence Program to Drive Oncology Companion Diagnostic Development in Europe HEIDELBERG, Germany and CARLSBAD, Calif., Sept. 7, 2017 /PRNewswire/ — Thermo Fisher Scientific has signed an agreement with the Institute of Pathology Heidelberg (IPH) to establish its Center of Molecular Pathology at Heidelberg University Hospital as... Read more

September 6, 2017 Clinical Research/Diagn. Product Launch

Bio-Techne Releases A Highly Sensitive and Specific Serological Assay to Detect Zika Virus Infections

MINNEAPOLIS, Sept. 6, 2017 /PRNewswire/ — R&D Systems®, a Bio-Techne brand, announced today the release of a new rapid, solid phase, enzyme-linked immunosorbent assay (ELISA) designed to measure anti-Zika virus immunoglobulin G (IgG) antibodies in human serum. A unique feature of this assay is that, prior to performing the test, samples are pre-treated with a proprietary... Read more